Gosset Ownership
Private
Employees
~100
Stage
Other
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Qiming Venture Partners General Information
Qiming Venture Partners is a leading China-based venture capital firm with global reach and an outstanding reputation for investing in early to growth-stage healthcare and technology startups. It manages over $9.5 billion in assets as of August 2024 and has backed numerous industry leaders across biotech/pharma/healthcare sectors both in China and internationally. Its U.S. arm focuses on transformative healthcare innovation with over $550 million raised since its founding in 2017.
Drug Pipeline
No pipeline data available
Key Partnerships
Investments often syndicated with major VCs such as Surveyor Capital, Sanofi Ventures, follow-on rounds sometimes led by Roche Venture Fund
Qiming Venture Partners Funding
No funding data available
To view Qiming Venture Partners's complete valuation and funding history, request access »